Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|May 7, 2016
The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trialDavid Oscier, Monica Else, Estella Matutes, et al.
Blood|December 7, 2007
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemiaClaire Dearden, Rachel Wade, Monica Else, et al.
British Journal of Haematology|September 26, 2015
An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapyNadav Sarid, Humayun N Ahmad, Andrew Wotherspoon, et al.
British Journal of Haematology|November 20, 2008
Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trialMonica Else, Alastair G Smith, Kim Cocks, et al.
Leukemia & Lymphoma|December 16, 2011
Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trialMonica Else, Kim Cocks, Shirley Crofts, et al.
British Journal of Haematology|May 19, 2012
The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphomaSarah L Hockley, Monica Else, Alison Morilla, et al.
Haematologica|June 1, 2010
Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocationDavid Oscier, Rachel Wade, Zadie Davis, et al.
Cancer|September 22, 2007
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemiaMonica Else, Nnenna Osuji, Francesco Forconi, et al.
Blood|September 28, 2011
Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous routeClaire E Dearden, Amit Khot, Monica Else, et al.
Haematologica|August 18, 2012
CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genesDavid Gonzalez, Monica Else, Dorte Wren, et al.
Pageof 4